ARCHIVES

NCI-Approved Clinical Trials Begun At Groups, Centers

This article is from The Cancer Letter archive.

Vol. 30 No. 11 | November 30, 2007

Download PDF Visit The Full Archive

Related Articles

NCI Faces Major Cuts On Gramm-Rudman Sequestration; Grants, Centers, Trials Slashed

November 3, 1989

Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment.

July 30, 2004

New Approaches To Therapy For Difficult Cancers Presented

June 29, 2007

NCI To Test 5,000 DC-Area Jews To Determine Risk Of BRCA 1 Mutation

October 6, 1995

NCI Says Breast Cancer Rate In Marin Matches Other West Coast Counties

April 18, 2003

NCCS Networker Volume 5 Issue 3, Summer 1991

June 13, 1991